EICHORCondition: Breast Cancer · Sponsor: Hoffmann-La Roche
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study will evaluate mechanisms of resistance to anti-breast cancer therapies in tumor and blood samples from participants with human epidermal growth factor receptor (HER2) positive, hormone receptor (HR) positive or triple negative breast cancer.
This description comes directly from the study's public registry record.
Reference Study ID Number: WO44977 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. Only) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Institut Jules Bordet | Anderlecht, Belgium | Recruiting |
| AZ KLINA | Brasschaat, Belgium | Recruiting |
| CHU de Liège (Sart Tilman) | Liège, Belgium | Recruiting |
| AZ Delta (Campus Rumbeke) | Roeselare, Belgium | Recruiting |
| Aalborg Universitetshospital | Aalborg, Denmark | Recruiting |
| Sjællands Universitetshospital, Næstved | Næstved, Denmark | Recruiting |
| Helsinki University Central Hospital | Helsinki, Finland | Recruiting |
| Tampere University Hospital | Tampere, Finland | Recruiting |
| St. Elisabeth Krankenhaus Köln GmbH | Cologne, Germany | Recruiting |
| KEM/Evang. Kliniken Essen Mitte gGmbH | Essen, Germany | Recruiting |
| ViDia Christliche Kliniken Karlsruhe, Vincentius-Diakonissen-Kliniken gAG | Karlsruhe, Germany | Recruiting |
| Universitätsklinikum Mannheim | Mannheim, Germany | Recruiting |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06274515